Table of Contents Asia-Pacific Influenza Medication Market Report 2017 1 Influenza Medication Overview 1.1 Product Overview and Scope of Influenza Medication 1.2 Classification of Influenza Medication by Product Category 1.2.1 Asia-Pacific Influenza Medication Market Size (Sales) Comparison by Types (2012-2022) 1.2.2 Asia-Pacific Influenza Medication Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Zanamivir 1.2.4 Oseltamivir phosphate 1.2.5 Peramivir 1.2.6 Other Influenza Medication 1.3 Asia-Pacific Influenza Medication Market by Application/End Users 1.3.1 Asia-Pacific Influenza Medication Sales (Volume) and Market Share Comparison by Applications (2012-2022) 1.3.2 adult 1.3.3 kids 1.4 Asia-Pacific Influenza Medication Market by Region 1.4.1 Asia-Pacific Influenza Medication Market Size (Value) Comparison by Region (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Japan Status and Prospect (2012-2022) 1.4.4 South Korea Status and Prospect (2012-2022) 1.4.5 Taiwan Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.4.7 Southeast Asia Status and Prospect (2012-2022) 1.4.8 Australia Status and Prospect (2012-2022) 1.5 Asia-Pacific Market Size (Value and Volume) of Influenza Medication (2012-2022) 1.5.1 Asia-Pacific Influenza Medication Sales and Growth Rate (2012-2022) 1.5.2 Asia-Pacific Influenza Medication Revenue and Growth Rate (2012-2022) 2 Asia-Pacific Influenza Medication Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Influenza Medication Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Influenza Medication Sales Volume and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Asia-Pacific Influenza Medication Revenue and Share by Players/Suppliers (2012-2017) 2.2 Asia-Pacific Influenza Medication (Volume and Value) by Type 2.2.1 Asia-Pacific Influenza Medication Sales and Market Share by Type (2012-2017) 2.2.2 Asia-Pacific Influenza Medication Revenue and Market Share by Type (2012-2017) 2.3 Asia-Pacific Influenza Medication (Volume) by Application 2.4 Asia-Pacific Influenza Medication (Volume and Value) by Region 2.4.1 Asia-Pacific Influenza Medication Sales and Market Share by Region (2012-2017) 2.4.2 Asia-Pacific Influenza Medication Revenue and Market Share by Region (2012-2017) 3 China Influenza Medication (Volume, Value and Sales Price) 3.1 China Influenza Medication Sales and Value (2012-2017) 3.1.1 China Influenza Medication Sales Volume and Growth Rate (2012-2017) 3.1.2 China Influenza Medication Revenue and Growth Rate (2012-2017) 3.1.3 China Influenza Medication Sales Price Trend (2012-2017) 3.2 China Influenza Medication Sales Volume and Market Share by Ty

List of Tables and Figures Figure Product Picture of Influenza Medication Figure Asia-Pacific Influenza Medication Sales Volume (K Units) by Type (2012-2022) Figure Asia-Pacific Influenza Medication Sales Volume Market Share by Type (Product Category) in 2016 Figure Zanamivir Product Picture Figure Oseltamivir phosphate Product Picture Figure Peramivir Product Picture Figure Other Influenza Medication Product Picture Figure Asia-Pacific Influenza Medication Sales (K Units) by Application (2012-2022) Figure Asia-Pacific Sales Market Share of Influenza Medication by Application in 2016 Figure adult Examples Table Key Downstream Customer in adult Figure kids Examples Table Key Downstream Customer in kids Figure Asia-Pacific Influenza Medication Market Size (Million USD) by Region (2012-2022) Figure China Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Japan Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure South Korea Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Taiwan Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure India Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Southeast Asia Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Australia Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Influenza Medication Sales Volume (K Units) and Growth Rate (2012-2022) Figure Asia-Pacific Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Influenza Medication Market Major Players Product Sales Volume (K Units)(2012-2017) Table Asia-Pacific Influenza Medication Sales (K Units) of Key Players/Suppliers (2012-2017) Table Asia-Pacific Influenza Medication Sales Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Influenza Medication Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Influenza Medication Sales Share by Players/Suppliers Figure Asia-Pacific Influenza Medication Market Major Players Product Revenue (Million USD) 2012-2017 Table Asia-Pacific Influenza Medication Revenue (Million USD) by Players/Suppliers (2012-2017) Table Asia-Pacific Influenza Medication Revenue Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Influenza Medication Revenue Share by Players Figure 2017 Asia-Pacific Influenza Medication Revenue Share by Players Table Asia-Pacific Influenza Medication Sales and Market Share by Type (2012-2017) Table Asia-Pacific Influenza Medication Sales Share by Type (2012-2017) Figure Sales Market Share of Influenza Medication by Type (2012-2017) Figure Asia-Pacific Influenza Medication Sales Growth Rate by Type (2012-2017) Table Asia-Pacific Influenza Medication Revenue (Million USD) and Market Share by Type